Recently, Cohen et al. were the first to demonstrate the usage of MHC tetramers for isolation of tumour-specific T cells from peripheral blood prior to expansion induced by immunotherapy (Cohen et al. 2015). The gene discussed is HLA-C; the disease is neoplasm.